key: cord-1014628-l8l0j90g
authors: Stauft, Charles B.; Lien, Christopher Z.; Selvaraj, Prabhuanand; Liu, Shufeng; Wang, Tony T.
title: The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters
date: 2021-01-25
journal: Virology
DOI: 10.1016/j.virol.2021.01.005
sha: 06a6041a057bdbf42b1c0e6cd1fc491f8e686aa2
doc_id: 1014628
cord_uid: l8l0j90g

Dynamic tracking of variant frequencies among viruses circulating in the global pandemic has revealed the emergence and dominance of a D614G mutation in the SARS-CoV-2 spike protein. To address whether pandemic SARS-CoV-2 G614 variant has evolved to become more pathogenic, we infected adult hamsters (>10 months old) with two natural SARS-CoV-2 variants carrying either D614 or G614 spike protein to mimic infection of the adult/elderly human population. Hamsters infected by the two variants exhibited comparable viral loads and pathology in lung tissues as well as similar amounts of virus shed in nasal washes. Altogether, our study does not find that naturally circulating D614 and G614 SARS-CoV-2 variants differ significantly in pathogenicity in hamsters.

the SARS-CoV-2 spike protein during the ongoing pandemic. 1 Of concern, the D614G mutation was associated with elevated viral loads observed in infected patients and enhanced replication of pseudotyped virions 1, 2 . However, there was no significant association between the D614G mutation and disease severity. 1 A very recent preprint reported that an engineered D614G mutation significantly enhances SARS-CoV-2 replication on human lung epithelial cells and primary human airway tissues 3 , and there is as of yet limited literature on the effects of mutations on SARS-CoV-2 pathogenesis. Because of the genomic proof-reading capacity of coronaviruses 4 , the observation of a new genotype overtaking the initial strain warrants close attention.

The question of whether the D614G mutation increases virulence or pathogenicity of SARS-CoV-2 in humans remains unanswered. We employed an adult hamster pathogenesis model to address whether SARS-CoV-2 evolution during the current pandemic resulted in increased pathogenesis. Syrian hamsters (Mesocricetus auratus) can live to be 18-24 months old and reach sexual maturity after ~12-13 weeks of age. However, studies commonly employ 5-10-week-old hamsters which are more logistically viable but immature. [5] [6] [7] [8] As advanced age strongly correlates with severe disease in COVID-19 patients 9 , aged hamsters support higher levels of viral replication than younger hamsters and even developed possibly lethal pneumonia after infection. 10 

To prepare sequencing libraries, 20 µl RNA was extracted from 140 µl virus stock and RNA quality was assessed by Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA)

to confirm that the RNA integration numbers (RIN) were all greater than 9. Library preparation 

Human codon-optimized cDNA encoding D614 SARS-CoV-2 S glycoprotein from the Wuhan-Hu- Values below detection limits were mathematically extrapolated based on the standard curves for graphing purpose.

Lung samples were fixed in 10% neural buffered formalin overnight and then processed for paraffin embedding. The 4-μm sections were stained with hematoxylin and eosin for histopathological examinations. Images were scanned using an Aperio ImageScope.

To detect SARS-CoV-2 genomic RNA in FFPE tissues, in situ hybridization (ISH) was performed using the RNAscope 2.5 HD RED kit, a single plex assay method (Advanced Cell Diagnostics;

Catalog 322373) following the manual according to the manufacturer's instructions with a probe targeting SARS-CoV-2 spike genomic (positive-sense) RNA (Supplementary methods).

We employed an adult hamster pathogenesis model to address whether SARS-CoV-2 evolution during the current pandemic resulted in increased pathogenesis. Syrian hamsters (Mesocricetus auratus) can live to be 18-24 months old and reach sexual maturity after ~12-13 weeks of age.

However, most studies employ 5-10-week-old hamsters 7,8 which are more logistically viable but immature. As advanced age strongly correlates with severe disease in COVID-19 patients, aged hamsters support higher levels of viral replication than younger hamsters and even developed possibly lethal pneumonia after infection (submitted). To allow head-to-head comparison between real-world variants, we cultured two virus isolates USA-WA1/2020 (D614) and New York- It was previously reported that VSV and lentiviral pseudoviruses expressing the G614 SARS-CoV-2 spike protein exhibit increased infectivity in vitro. 1, 2, 11 Confirming these prior studies with wild-type SARS-CoV-2, we noticed that the viral stocks of G614 were up to 5 times higher than D614 in Vero E6 cells, however, the plaque size was not observed to be markedly different between the two ( Figure 1D ). Although increased replication was observed in cultured cells, we tested whether a G614 SARS-CoV-2 clinical isolate would show increased replication, pathogenicity, and shedding in vivo. To test these hypotheses, we inoculated adult Syrian hamsters (11 months old) by the intranasal route with 1,000 TCID 50 of D614 or G614 SARS-CoV-2 and measured viral loads post-infection in lungs and nasal washes to compare virulence ( Figure 1 ). Viral RNA levels in nasal washes were not found to be significantly different on days 1, 2, or 3 post-infection ( Figure 1A ) while infectious viral titers (TCID 50 ) were slightly but significantly (p=0.0363, Student's t-test) lower in the nasal washes of G614 infected hamsters ( Figure 1B) . On J o u r n a l P r e -p r o o f day 3, lungs (n=3) from both treatment groups were removed for titration and pathology.

Replicating virus was targeted using quantification of subgenomic RNA by qRT-PCR, however, no difference was observed between D614 and G614 infected hamsters ( Figure 1C ) Abundant atypical hyperplasia and hypertrophy of terminal bronchiolar epithelial cells and pneumocytes were noticed along with interstitial lymphocytic infiltrates. Nonetheless, there were no significant differences between the two groups.

Although multiple studies, including ours, show the G614 variant grows to a higher titer 1, 2, 11 , it is unclear whether the fixation of D614G spike mutation is the result of a founder effect as the SARS-CoV-2 pandemic spread to Europe and the Americas or a product of viral evolution in response to a new host or to some other selective pressure. Rather than use recombinant SARS- Nonetheless, choosing real-world isolates makes our model more relevant to study the ongoing COVID-19 pandemic.

In the adult Syrian hamster model, we were unable to discern a detectable increase in pathogenicity with a G614 isolate of SARS-CoV-2 in hamsters, as has been observed clinically.

Although recovery of body weight in infected hamsters was observed by day 12, continued lung pathology was still observable in lung tissues, with no marked difference between the two strains of SARS-CoV-2. Therefore, G614 may confer some growth advantage over the original D614

form but does not alter the overall pathogenicity of the virus.

In this study, adult Syrian hamsters infected by either a natural D614 or G614 SARS-CoV-2 variant did not exhibit significant differences in terms of viral loads and histopathology in the lung, arguing that naturally circulating D614 and G614 SARS-CoV-2 variants do not differ significantly in pathogenicity in hamsters. 

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain. bioRxiv

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility. bioRxiv

Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters

Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19)

Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility

A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model. bioRxiv

Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan

The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat raTG13. bioRxiv

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv

Aged hamsters (>10 months old) show comparable weight loss, neutralizing antibody titers, and pathology after infection with either D614 or G614 SARS-CoV-2. Following intranasal inoculation of adult hamsters with 10 5 TCID 50 SARS-CoV-2 D614 (red circles) or G614 (green squares), morbidity (weight loss) was followed daily for 12 days postinfection (A)

The following reagents were deposited by the Centers for Diseases Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52281; Isolate New York-PV08410/2020, NR-53514.